Clinical Trials Browser

Phase 2 × Urologic Neoplasms × Zoledronic Acid × Clear all

NCT00226954 2020-03-18

Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate Cancer

Phase 2 Terminated

Urologic Neoplasms